IN2014MN02236A - - Google Patents

Download PDF

Info

Publication number
IN2014MN02236A
IN2014MN02236A IN2236MUN2014A IN2014MN02236A IN 2014MN02236 A IN2014MN02236 A IN 2014MN02236A IN 2236MUN2014 A IN2236MUN2014 A IN 2236MUN2014A IN 2014MN02236 A IN2014MN02236 A IN 2014MN02236A
Authority
IN
India
Prior art keywords
composition
aqueous
voriconazole
prevention
preparing
Prior art date
Application number
Inventor
Shrinivas Purandare
Geena Malhotra
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Priority to IN2236MUN2014 priority Critical patent/IN2014MN02236A/en
Publication of IN2014MN02236A publication Critical patent/IN2014MN02236A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to a pharmaceutical composition comprising voriconazole and an aqueous non aqueous or oily vehicle or a mixture thereof and optionally one or more pharmaceutically acceptable excipients; to a process for preparing such a composition and to the use of such a composition for the prevention or treatment of fungal infections.
IN2236MUN2014 2012-05-11 2013-05-10 IN2014MN02236A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN2236MUN2014 IN2014MN02236A (en) 2012-05-11 2013-05-10

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1444MU2012 2012-05-11
PCT/GB2013/000211 WO2013167865A1 (en) 2012-05-11 2013-05-10 Pharmaceutical composition
IN2236MUN2014 IN2014MN02236A (en) 2012-05-11 2013-05-10

Publications (1)

Publication Number Publication Date
IN2014MN02236A true IN2014MN02236A (en) 2015-07-24

Family

ID=48485212

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2236MUN2014 IN2014MN02236A (en) 2012-05-11 2013-05-10

Country Status (12)

Country Link
US (1) US20150133472A1 (en)
EP (1) EP2846769A1 (en)
JP (1) JP2015516409A (en)
KR (1) KR20150028241A (en)
CN (1) CN104519867A (en)
AU (1) AU2013257830A1 (en)
BR (1) BR112014028069A2 (en)
CA (1) CA2872958A1 (en)
IN (1) IN2014MN02236A (en)
MX (1) MX2014013714A (en)
RU (1) RU2014149993A (en)
WO (1) WO2013167865A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2887923B1 (en) 2012-08-24 2023-04-05 Sun Pharmaceutical Industries Limited Ophthalmic formulation of polyoxyl lipid or polyoxyl fatty acid and treatment of ocular conditions
BR112016027379A2 (en) * 2014-05-23 2018-06-26 Ocular Tech Sarl topical formulations and their uses
US9421199B2 (en) 2014-06-24 2016-08-23 Sydnexis, Inc. Ophthalmic composition
US11382909B2 (en) 2014-09-05 2022-07-12 Sydnexis, Inc. Ophthalmic composition
WO2016182032A1 (en) * 2015-05-12 2016-11-17 参天製薬株式会社 Administration of azole antifungal agent to eyelid skin
WO2016196367A1 (en) 2015-05-29 2016-12-08 Sydnexis, Inc. D2o stabilized pharmaceutical formulations
US10918694B2 (en) 2016-02-29 2021-02-16 Sun Pharma Global Fze Topical cyclosporine-containing formulations and uses thereof
DK3266446T3 (en) * 2016-07-07 2019-02-11 Salvat Lab Sa Eye preparation comprising castor oil and medium chain triglyceride
CN106390130B (en) * 2016-09-18 2018-06-01 中国人民解放军第二军医大学 Purposes of the niacinamide as antifungal medicine synergist
ES2932359T3 (en) * 2017-11-06 2023-01-18 Dermalena Di Calderan Andrea Formulation based on N-acetylcysteine and urea for the treatment of dermatological disorders

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8819308D0 (en) 1988-08-13 1988-09-14 Pfizer Ltd Triazole antifungal agents
KR0166088B1 (en) 1990-01-23 1999-01-15 . Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
GB9002375D0 (en) 1990-02-02 1990-04-04 Pfizer Ltd Triazole antifungal agents
GB9713149D0 (en) 1997-06-21 1997-08-27 Pfizer Ltd Pharmaceutical formulations
US20040198829A1 (en) * 2001-04-23 2004-10-07 Sponsel William Eric Prostanoids augment ocular drug penetration
GB0327390D0 (en) * 2003-11-25 2003-12-31 Pfizer Ltd Pharmaceutical formulations
US20050112204A1 (en) 2003-11-25 2005-05-26 Pfizer Inc. Pharmaceutical formulations
US9132071B2 (en) * 2006-07-28 2015-09-15 Santen Sas Compositions containing quaternary ammonium compounds
CN1962683A (en) * 2006-12-18 2007-05-16 张文芳 Polyethylene glycol modified sterol copolymer and its uses
ES2493641T3 (en) * 2007-06-28 2014-09-12 Cydex Pharmaceuticals, Inc. Nasal administration of aqueous corticosteroid solutions
EP2027850A1 (en) * 2007-08-22 2009-02-25 Sandoz AG Pharmaceutical compositions containing voriconazole
WO2011064558A2 (en) * 2009-11-30 2011-06-03 Cipla Limited Pharmaceutical composition

Also Published As

Publication number Publication date
CA2872958A1 (en) 2013-11-14
RU2014149993A (en) 2016-07-10
WO2013167865A1 (en) 2013-11-14
JP2015516409A (en) 2015-06-11
CN104519867A (en) 2015-04-15
AU2013257830A1 (en) 2014-11-20
EP2846769A1 (en) 2015-03-18
KR20150028241A (en) 2015-03-13
BR112014028069A2 (en) 2017-08-08
US20150133472A1 (en) 2015-05-14
MX2014013714A (en) 2015-08-10

Similar Documents

Publication Publication Date Title
IN2014MN02236A (en)
PH12015500274B1 (en) Alkylpyrimidine derivatives for the treatment of viral infections and further diseases
PH12016501122A1 (en) Delayed release compositions of linaclotide
PH12014501738A1 (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
PH12015500983A1 (en) Heterocyclic substituted 2-amino-quinazoline derivatives for the treatment of viral infections
PH12016501790A1 (en) Pharmaceutical compositions of therapeutically active compounds
MX370543B (en) Vegf neutralizing prodrugs for the treatment of ocular conditions.
GB201118656D0 (en) New compounds
PH12016501788A1 (en) Pharmaceutical compositions of therapeutically active compounds
PH12015500724A1 (en) 1, 2, 4-triazine derivatives for the treatment of viral infections
PH12015501156A1 (en) Pharmaceutical compositions
IN2013MU03583A (en)
IN2014DN10670A (en)
MX2016002580A (en) Combination of an alk inhibitor and a cdk inhibitor for the treatment of cell proliferative diseases.
EA032271B9 (en) Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases
WO2014033526A9 (en) Pharmaceutical compositions of etoricoxib
MX366829B (en) Itraconazole compositions and dosage forms, and methods of using the same.
MX2015011588A (en) Combination treatment.
IN2014DN03010A (en)
MX2017002544A (en) Isoquinolinone derivatives useful in the treatment of cancer.
GB201114923D0 (en) Immunogenic proteins and compositions
IN2014KN02584A (en)
MX2012014498A (en) Rosuvastatin pharmaceutical composition.
IN2013MU03838A (en)
IN2013MU01160A (en)